Myome

Founded with the mission to provide comprehensive insights into disease risk and medication response, Myome offers clinical-grade whole genome sequencing services. Their core product, MyOme Personal Genome™, delivers detailed health insights through two initial reports: the Proactive Health Report and the Pharmacogenomics Report. These reports are reviewed by independent physicians and supplemented with one-on-one genetic counseling, enabling users to make informed health decisions throughout their lives. The service is FSA/HSA eligible, making it accessible to a broader market focused on proactive health management.

Notable affiliated individuals include experts in genomics and healthcare, contributing to the company's credibility and expertise. Myome has achieved significant milestones in offering clinically relevant genomic data that aids in disease prevention, early detection, and medication management. Their impact is evident in the personalized healthcare space, where they empower individuals with actionable genetic information, thereby enhancing overall health outcomes and advancing the field of personalized medicine.